SMTL ID : 4rdd.1

Co-crystal structure of SHP2 in complex with a Cefsulodin derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x 3LU: 1-({(2R)-4-carboxy-2-[(R)-carboxy{[(2R)-2-phenyl-2-sulfoacetyl]amino}methyl]-3,6-dihydro-2H-1,3-thiazin-5-yl}methyl)pyr idinium(Non-covalent)

3LU.1: 12 residues within 4Å: Chain A: Y.18, I.21, C.198, S.199, A.200, G.201, I.202, G.203, R.204, Q.245, T.246, Q.249 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.18, A:I.21, A:A.200 Hydrogen bonds: A:S.199, A:A.200, A:G.201, A:I.202, A:G.203, A:R.204, A:Q.249 Water bridges: A:R.101, A:G.166, A:R.204, A:R.204, A:R.204

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, R. et al., Exploring the Existing Drug Space for Novel pTyr Mimetic and SHP2 Inhibitors. ACS Med Chem Lett (2015)

Release Date

2015-07-01

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11